Theofanis Karaletsos

NEW: Achira has launched with a $33M seed round

I talked with CEO @jchodera.bsky.social about plans to combine AI- and physics-based methods for drug discovery and moving beyond 45 years of the same type of models behind molecular dynamics.

My latest @endpts.com:

endpts.com/achira-raise...

Achira will transform drug discovery by building atomistic foundation models for biomolecular simulation and leverage massive computation, generative AI, and the frontiers of physics-based synthetic data generation.

Excited to be on this journey with @jchodera.bsky.social and this dream team.